Erivedge (vismodegib) — Medica
Diffuse basal cell carcinoma formation (including basal cell nevus syndrome, Gorlin syndrome, or other genetic forms of multiple basal cell carcinoma)
Initial criteria
- age ≥ 18 years
Approval duration
1 year
Diffuse basal cell carcinoma formation (including basal cell nevus syndrome, Gorlin syndrome, or other genetic forms of multiple basal cell carcinoma)
1 year